Trials / Completed
CompletedNCT00337545
Phase II Trial of RAD001 in Refractory Colorectal Cancer
Phase II Trial of RAD001 in Patients With Refractory Colorectal Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Swedish Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Single center open-label study of an oral agent (RAD001) in subjects with metastatic colorectal cancer refractory to at least 2 standard chemo/biologic regimens.
Detailed description
Study is completed and closed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RAD001 |
Timeline
- Start date
- 2006-05-01
- Completion
- 2007-04-01
- First posted
- 2006-06-16
- Last updated
- 2007-10-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00337545. Inclusion in this directory is not an endorsement.